Maximus (NYSE:MMS – Get Free Report) is projected to post its quarterly earnings results before the market opens on Thursday, February 6th. Analysts expect Maximus to post earnings of $1.39 per share and revenue of $1.29 billion for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.
Maximus Stock Performance
Shares of MMS stock opened at $75.37 on Thursday. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59. Maximus has a 52 week low of $69.72 and a 52 week high of $93.97. The stock has a market capitalization of $4.54 billion, a PE ratio of 15.07 and a beta of 0.73. The firm has a 50 day moving average of $74.64 and a two-hundred day moving average of $84.15.
Maximus Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Saturday, February 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.59%. Maximus’s dividend payout ratio is presently 24.00%.
Insider Transactions at Maximus
Analysts Set New Price Targets
Several equities analysts have commented on the stock. Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target for the company in a research report on Thursday, January 2nd. StockNews.com raised shares of Maximus from a “hold” rating to a “buy” rating in a research report on Wednesday.
View Our Latest Stock Report on MMS
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Read More
- Five stocks we like better than Maximus
- What is a Death Cross in Stocks?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- What Are Dividend Achievers? An Introduction
- 3 Steel Stocks Soaring After Tariff Announcements
- Following Congress Stock Trades
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.